Does echinacea work for colds? A big review and a 719-person trial say barely

Echinacea sells hard every cold season, but the evidence for it is weak. The most thorough review found no reliable benefit for treating a cold and only a faint, uncertain hint that it might slightly reduce your chances of catching one; the largest single trial trimmed barely half a day off a cold, an effect too small to distinguish from chance [s1][s2]. The realistic answer is "probably not, and if at all, barely."

The problem with "echinacea"

Part of the reason the evidence is muddy is that "echinacea" is not one product. Preparations differ by plant species, by which part of the plant is used, and by extraction method, so trials are not really testing the same thing [s1]. That heterogeneity is why the 2014 Cochrane review — the definitive synthesis — declined to pool most of its studies into a single number, and instead reported them as the mixed bag they are [s1].

What the big review found

That review gathered 24 double-blind trials with 4,631 participants, yielding 33 comparisons of an echinacea preparation against placebo [s1]. Trial quality was uneven — 10 were judged at low risk of bias, 6 unclear and 8 at high risk — which further limits how much weight any single positive result can carry [s1]. On treatment, the results were flat: of the seven treatment trials that reported cold duration, only one showed a statistically significant advantage for echinacea over placebo [s1]. The reviewers' conclusion was blunt — echinacea products had not been shown to benefit the treatment of colds [s1].

Prevention was marginally more interesting, but still short of convincing. None of the 12 prevention comparisons that counted how many people caught at least one cold found a statistically significant difference on its own [s1]. A post-hoc pooling of those results suggested a relative risk reduction somewhere between 10% and 20% — but the reviewers stressed this was a weak signal of questionable clinical relevance, not a reliable effect [s1]. In plain terms: if there is any benefit, it is small, unproven, and might be for prevention rather than treatment.

The largest single trial

The biggest and most carefully run treatment trial reached the same place. Published in 2010, it enrolled 719 people aged 12 to 80 with a new cold and assigned them to no pills, blinded placebo, blinded echinacea, or open-label echinacea, with the echinacea groups getting the equivalent of 10.2 g of dried echinacea root on the first day [s2].

The differences were tiny and not significant. Mean illness duration was 6.34 days in the blinded echinacea group versus 6.87 days on blinded placebo — a benefit of about 0.53 of a day (95% confidence interval −1.25 to 0.19, p = 0.075) [s2]. Symptom severity showed a similar 28-point trend toward echinacea that also fell short of significance (95% CI −69 to 13, p = 0.089) [s2]. Objective markers agreed: interleukin-8 levels and neutrophil counts sampled from nasal-wash fluid did not differ meaningfully between the echinacea and placebo groups [s2]. The authors concluded the results did not support the ability of this echinacea formulation to substantively change the course of a cold [s2]. Even taken at face value, half a day off a week-long cold is not what the packaging implies.

Safety and the sensible reading

Echinacea's safety record in these trials was reassuring: dropouts and adverse events did not differ significantly from placebo, though prevention trials showed a trend toward more people stopping because of side effects on echinacea [s1]. So the case against it is not that it is dangerous — it is that it mostly does not work, and the possible sliver of prevention benefit is too uncertain to bank on [s1][s2].

Bottom line

Does echinacea work? On the best evidence, barely if at all. A 24-trial Cochrane review found no reliable treatment effect and only a weak, questionable prevention signal, and the largest trial cut a cold by about half a day, within the range of chance [s1][s2]. It sits with the other over-marketed cold remedies whose reputations outrun their trials — see the parallel evidence on zinc lozenges and vitamin C. If a cold turns severe or lingers, that is a reason to see a clinician, not to double the dose.

This article is informational and not medical advice.

Sources

• Echinacea for preventing and treating the common cold — Cochrane Database of Systematic Reviews, 2014-02-20
• Echinacea for Treating the Common Cold: A Randomized Trial — Annals of Internal Medicine, 2010-12-21